Tokyo, March 24, 2017 --- Hitachi, Ltd. today announced that it will post an impairment loss of approximately 65 billion yen (assuming the exchange rate is 110 yen per U.S. dollar) for the commercial development of a laser-based uranium enrichment technology advanced by GE-Hitachi Nuclear Energy Holdings LLC, an equity-method associate in U.S., as share of losses of investments accounted for using the equity method on consolidated financial results for the fiscal year ending March 31, 2017. The amount of impairment loss is current estimate, and will be settled in consolidated financial results for the three months ending March 31, 2017.
Consolidated business forecasts for the year ending March 31, 2017 announced on February 1, 2017 are not changed.
